MM

Mukesh Mehta

Active Director Whole-Time Director DIN 03187420
DIN 03187420 First appointment Apr 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Apr 2011
Shareholding value •••• Premium profile

About Mukesh Mehta

Data last updated:

Mukesh Mehta is a Whole-Time Director at Bio Medica Laboratories Limited (since 2015) and Additional Director at Vitamax Healthcare Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹43.64 Cr; the largest is Bio Medica Laboratories Limited at ₹38.33 Cr (FY 2025). Earlier, Mukesh Mehta was a Director at Italia Pharmaceuticals Private Limited (2022–2024) and Director at Horster Biotek Private Limited (2015–2020) and 1 more.

DIN 03187420
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 27 Apr 2011
Oldest Company Age 18 yrs
Largest company Bio Medica Laboratories Limited · ₹38.33 Cr (FY 2025)
Combined revenue ₹43.64 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bio Medica Laboratories Limited U24230MP2015PLC034576
Whole-Time Director14 Aug 20152015₹38.33 Cr (FY 2025)Active
Vitamax Healthcare Private Limited U24230MP2008PTC020939
Additional Director08 Oct 20252008₹5.31 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Dec 20221996₹84.3 Lakh (FY 2024)Active
Horster Biotek Private Limited U24232MP2010PTC024892
Director09 Mar 20152010₹9.25 Cr (FY 2025)Active
Akron Chemicals Private Limited U24100MP2011PTC025875
Director27 Apr 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Akron Chemicals Private Limited
Vitamax Healthcare Private Limited
Bio Medica Laboratories Limited
Italia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mukesh Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Mehta

Mukesh Mehta currently holds 2 directorships: Bio Medica Laboratories Limited (Whole-Time Director, since 14 Aug 2015, revenue ₹38.33 Cr (FY 2025)); Vitamax Healthcare Private Limited (Additional Director, since 08 Oct 2025, revenue ₹5.31 Cr (FY 2025)).

Mukesh Mehta was first appointed on 27 Apr 2011 as Director at Akron Chemicals Private Limited. The most recent appointment on record is 08 Oct 2025 at Vitamax Healthcare Private Limited.

The 2 current companies of Mukesh Mehta that report revenue have a combined latest revenue of ₹43.64 Cr: Bio Medica Laboratories Limited ₹38.33 Cr (FY 2025); Vitamax Healthcare Private Limited ₹5.31 Cr (FY 2025).

Mukesh Mehta held 3 earlier board appointments: Italia Pharmaceuticals Private Limited (Director, 06 Dec 2022 to 28 May 2024); Horster Biotek Private Limited (Director, 09 Mar 2015 to 27 Jan 2020); Akron Chemicals Private Limited (Director, from 27 Apr 2011).

The current boards of Mukesh Mehta's companies include Divya Khandelwal (Bio Medica Laboratories Limited), Kavita Thakur (Bio Medica Laboratories Limited), Pradeep Mehta (Bio Medica Laboratories Limited), Rahul Kumar (Bio Medica Laboratories Limited), Santosh Kale (Bio Medica Laboratories Limited), Sumeet Bansal (Bio Medica Laboratories Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available